Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort Study

Abstract Introduction International guidelines recommend definitive combination antibiotic therapy for the management of serious infections involving carbapenem-resistant Acinetobacter (CRAB) species. The commonly available combination options include high-dose sulbactam, polymyxins, tetracyclines,...

Full description

Bibliographic Details

Published in:	Infectious Diseases and Therapy
Main Authors:	Abi Manesh, Mithun Mohan George, Prasannakumar Palanikumar, V. Nagaraj, Kundakarla Bhanuprasad, Ramya Krishnan, G. Nivetha, Binesh Lal, K. Rajitha Triveni, Priyanka Gautam, Biju George, Uday Kulkarni, Vikram Mathews, K. Subramani, Shoma Rao, Binila Chacko, Anand Zachariah, Sowmya Sathyendra, Samuel George Hansdak, Ooriapadickal Cherian Abraham, Ramya Iyadurai, Rajiv Karthik, John Victor Peter, Yin Mo, Balaji Veeraraghavan, George M. Varghese, David Leslie Paterson
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2024-09-01
Subjects:	Acinetobacter Combination therapy CRAB infections Polymyxins
Online Access:	https://doi.org/10.1007/s40121-024-01042-w